FDA Import Refusal 799-8801258-1/10002/3 — ASTRAZENECA KOREA
The FDA refused shipment 799-8801258-1/10002/3 from ASTRAZENECA KOREA (South Korea) on Nov 18, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,3280
Refusal details
- Date
- Nov 18, 2025
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,3280